Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

Blood (2020) 136 (Supplement 1): 56–58.

https://doi.org/10.1182/blood-2020-138834

Published: 2020

Journal Articles

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis

Samuel Rubinstein, MD, Ryan C. Lynch, MD, Aakash Desai, MD, Catherine Stratton, MPH, Alokkumar Jha, PhD, Ziad Bakouny, MD MSc, Andrew Schmidt, MD, R. Alejandro Sica, MD, Divaya Bhutani, MD, Dimpy P. Shah, MD PhD, Sarah A Wall, MD, Gary H. Lyman, MD, Nicole M. Kuderer, MD MSc, Matthias Weiss, MD PhD, Jeremy L. Warner, MD MS, Keith E. Stockerl-Goldstein, MD, Ruben Mesa, MD, Michael A. Thompson, MD PhD

Blood (2020) 136 (Supplement 1): 28–30.

https://doi.org/10.1182/blood-2020-141937

Published: 2020

Journal Articles

The Rate of Venous Thromboembolism in Cancer Patients Varies By Khorana Risk Category

Alok A. Khorana, MD, Nicole M. Kuderer, MD, Keith R. McCrae, MD, Dejan Milentijevic, PhD, Guillaume Germain, MA, François Laliberté, MA, Nguyen Le, BSc, Patrick Lefebvre, MA, Gary H. Lyman, MD MPH, FRCP, Michael B. Streiff, MD

Blood (2018) 132 (Supplement 1): 3798.

https://doi.org/10.1182/blood-2018-99-116224

Published: 2018

Journal Articles

Healthcare Costs in Patients with Cancer Increase with Increasing Risk of Venous Thromboembolism

Michael B. Streiff, MD, Keith R. McCrae, MD, Nicole M. Kuderer, MD, Dejan Milentijevic, PhD, Guillaume Germain, MA, François Laliberté, MA, Nguyen Le, BSc, Patrick Lefebvre, MA, Gary H. Lyman, MD MPH, FRCP, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 3799.

https://doi.org/10.1182/blood-2018-99-117121

Published: 2018

Journal Articles

A Meta-Analysis of the Prognostic Accuracy of Clinical Prediction Rules for Post-Pulmonary Embolism Mortality in Patients with Cancer

Jonathan Caranfa, PharmD, Christine G. Kohn, BS, PharmD, Gary H. Lyman, MD MPH, FRCP, Nicole M. Kuderer, MD, Catherine Stirbis, BS, Mark Wysocki, PharmD, Craig I. Coleman, PharmD, Erin R Weeda, PharmD, Elaine Nguyen, PharmD

Blood (2017) 130 (Supplement 1): 2105.

https://doi.org/10.1182/blood.V130.Suppl_1.2105.2105

Published: 2017

Journal Articles

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Davendra P. S. Sohal, MD MPH, Nicole M. Kuderer, MD, Frances A. Shepherd, MD FRCPC, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Gary H. Lyman, MD MPH, Alok A. Khorana, MD

Blood (2016) 128 (22): 1422.

https://doi.org/10.1182/blood.V128.22.1422.1422

Published: 2016

Journal Articles

Application of a Validated Predictive Model for Venous Thromboembolism in Cancer to Patients with Multiple Myeloma

Natasha Catherine Edwin, MD, Jesse Keller, MD, Suhong Luo, MS, Kenneth R Carson, MD, Brian F. Gage, MDMSc, Nicole M. Kuderer, MD, David Calverley, MD, Kristen M. Sanfilippo, MD

Blood (2016) 128 (22): 534.

https://doi.org/10.1182/blood.V128.22.534.534

Published: 2016

Journal Articles

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Nicole M. Kuderer, MD, Marek S. Poniewierski, MD MS, MS, Eva Culakova, PhD MS, Gary H. Lyman, MD MPH, Alok A. Khorana, MD, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Frances A. Shepherd, MD FRCPC

Blood (2016) 128 (22): 3590.

https://doi.org/10.1182/blood.V128.22.3590.3590

Published: 2016

Journal Articles

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Gary H. Lyman, MD MPH, Eva Culakova, PhD MS, Marek S. Poniewierski, MD MS, MS, Nicole M. Kuderer, MD

Blood (2016) 128 (22): 4751.

https://doi.org/10.1182/blood.V128.22.4751.4751

Published: 2016

Journal Articles

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Gary H. Lyman, MD MPH, Eva Culakova, PhD MS, Marek S. Poniewierski, MD MS, Nicole M. Kuderer, MD

Blood (2014) 124 (21): 2613.

https://doi.org/10.1182/blood.V124.21.2613.2613

Published: 2014

Journal Articles

Risk Score For Venous Thromboembolism (VTE) In Ambulatory Patients: Impact Of Cancer Type and Risk Score On VTE Incidence, Early Mortality and Progression-Free Survival

Nicole M. Kuderer, MD, Alok A. Khorana, MD, Charles Francis, Eva Culakova, PhD, MS, Gary H. Lyman, M.D., M.P.H.

Blood (2013) 122 (21): 3597.

https://doi.org/10.1182/blood.V122.21.3597.3597

Published: 2013

Journal Articles

Personalizing Cancer Supportive Care: Predicting Neutropenic Complications in Patients Receiving Intermediate Risk Cancer Chemotherapy

Gary H. Lyman, MD, MPH, Eva Culakova, PhD, MS, Marek S. Poniewierski, MD, MS, Jeffrey Crawford, MD, David C. Dale, MD, Nicole M. Kuderer, MD

Blood (2011) 118 (21): 1022.

https://doi.org/10.1182/blood.V118.21.1022.1022

Published: 2011

Journal Articles

Overall Survival of Lymphoma Patients In Randomized Controlled Trials Comparing Primary G-CSF Chemotherapy Support to Control.

Gary H. Lyman, MD, MPH, Jeffrey Crawford, Eva Culakova, PhD, MS, Marek S. Poniewierski, MD, MS, Mingyan Huang, Nicole M. Kuderer, MD, David C. Dale, MD

Blood (2010) 116 (21): 1502.

https://doi.org/10.1182/blood.V116.21.1502.1502

Published: 2010

Journal Articles

Low Molecular Weight Heparin Thromboprophylaxis in Ambulatory Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Nicole M. Kuderer, MD, Thomas L. Ortel, MD, PhD, Alok A Khorana, MD, Charles W. Francis, MD, Gary H. Lyman, MD, MPH

Blood (2009) 114 (22): 490.

https://doi.org/10.1182/blood.V114.22.490.490

Published: 2009

Journal Articles

Acute Myeloid Leukemia or Myelodysplastic Syndromes and All-Cause Mortality in Randomized Controlled Trials of Cancer Patients Receiving Chemotherapy with or without Granulocyte Colony-Stimulating Factor: A Systematic Review and Meta-Analysis.

Gary H. Lyman, MD, MPH, Jeffrey Crawford, MD, Eva Culakova, PhD, MS, Marek S. Poniewierski, MD, MS, Debra Wolff, MS, PCNP, Nicole M. Kuderer, MD, David C. Dale, MD

Blood (2009) 114 (22): 3100.

https://doi.org/10.1182/blood.V114.22.3100.3100

Published: 2009

Journal Articles

Final Risk Prediction Model for Neutropenic Complications in Patients Receiving Cancer Chemotherapy

Gary H. Lyman, MD, MPH, Jeffrey Crawford, MD, Nicole M. Kuderer, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, MS, Marek S. Poniewierski, MD, MS, David C. Dale, MD

Blood (2008) 112 (11): 1312.

https://doi.org/10.1182/blood.V112.11.1312.1312

Published: 2008

Journal Articles

Venous Thromboembolism Risk Model Predicts Early Progression and Overall Mortality in Cancer Patients Receiving Chemotherapy

Nicole M. Kuderer, MD, Alok A. Khorana, MD, Charles W. Francis, MD, Eva Culakova, PhD, MS, Thomas L. Ortel, MD, PhD, Anna Falanga, MD, Gary H. Lyman, MD, MPH

Blood (2008) 112 (11): 172.

https://doi.org/10.1182/blood.V112.11.172.172

Published: 2008

Journal Articles

Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Gary H. Lyman, MD, MPH, David C. Dale, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, MS, Nicole M. Kuderer, MD, Marek S. Poniewierski, MD, MS, Jeffrey Crawford, MD

Blood (2008) 112 (11): 2390.

https://doi.org/10.1182/blood.V112.11.2390.2390

Published: 2008

Journal Articles

A Conditional Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

Gary H. Lyman, MD, MPH, FRCP, Jeffrey Crawford, MD, Nicole M. Kuderer, MD, Debra A. Wolff, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, David C. Dale, MD

Blood (2007) 110 (11): 372.

https://doi.org/10.1182/blood.V110.11.372.372

Published: 2007

Journal Articles

Prospective Validation of a Predictive Model for Early Anemia in Patients Receiving Cancer Chemotherapy.

Gary H. Lyman, MD, MPH, FRCP, David C. Dale, MD, Nicole M. Kuderer, MD, Debra A. Wolff, MS, PCNP, Eva Culakova, PHD, Marek S. Poniewierski, MD, MS, Jeffrey Crawford, MD, for the ANC Study Group

Blood (2006) 108 (11): 460.

https://doi.org/10.1182/blood.V108.11.460.460

Published: 2006

NARROW

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis

The Rate of Venous Thromboembolism in Cancer Patients Varies By Khorana Risk Category

Healthcare Costs in Patients with Cancer Increase with Increasing Risk of Venous Thromboembolism

A Meta-Analysis of the Prognostic Accuracy of Clinical Prediction Rules for Post-Pulmonary Embolism Mortality in Patients with Cancer

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Application of a Validated Predictive Model for Venous Thromboembolism in Cancer to Patients with Multiple Myeloma

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Risk Score For Venous Thromboembolism (VTE) In Ambulatory Patients: Impact Of Cancer Type and Risk Score On VTE Incidence, Early Mortality and Progression-Free Survival

Personalizing Cancer Supportive Care: Predicting Neutropenic Complications in Patients Receiving Intermediate Risk Cancer Chemotherapy

Overall Survival of Lymphoma Patients In Randomized Controlled Trials Comparing Primary G-CSF Chemotherapy Support to Control.

Low Molecular Weight Heparin Thromboprophylaxis in Ambulatory Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Acute Myeloid Leukemia or Myelodysplastic Syndromes and All-Cause Mortality in Randomized Controlled Trials of Cancer Patients Receiving Chemotherapy with or without Granulocyte Colony-Stimulating Factor: A Systematic Review and Meta-Analysis.

Final Risk Prediction Model for Neutropenic Complications in Patients Receiving Cancer Chemotherapy

Venous Thromboembolism Risk Model Predicts Early Progression and Overall Mortality in Cancer Patients Receiving Chemotherapy

Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome

A Conditional Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

Prospective Validation of a Predictive Model for Early Anemia in Patients Receiving Cancer Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only